Price $7.49 |
Market Cap
430.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.69
|
P/S
2.0
|
Dividend %
-
|
|
P/CF
10.6
|
P/FCF
-
|
Op. Cash Flow
-82.3K
|
FCF
-1.8
|
|
Op. Margin
-32.70%
|
Net Margin
-30.60%
|
ROE
-46.70%
|
ROI
-65.20%
|
|
ROA
-17.50%
|
EPS Growth
63.70%
|
Current Ratio
2.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Oncolytics Biotech, Inc. (USA) (ONCY) | $2.75 | - | - | 49.2M | Strong Buy |
| RTI Surgical Inc (RTIX) | $4.40 | - | - | 289.6M | Strong Buy |
| Altimmune Inc (ALT) | $3.28 | - | - | 16.5M | Strong Buy |
| Sangamo Therapeutics Inc (SGMO) | $9.51 | - | - | 1.42B | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.65 | - | - | 146.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
